Search Results

Ethypharm establishes direct presence in Italy

Ethypharm announces that it now has a fully established affiliate to operate directly in Italy, the third largest pharmaceutical market in Europe.

April 23, 2021

·

2 min read

Ethypharm reinforces its late-stage R&D pipeline with a novel acute treatment of migraine

Ethypharm announces that it has acquired the exclusive rights for the development, registration and commercialization in the top 5 European markets of a novel celecoxib formulation already approved in the US for the acute treatment of migraine.

May 19, 2021

·

3 min read

Deals

Ethypharm to acquire Altan Pharma, entering the Spanish market and enhancing its Critical Care portfolio and R&D pipeline

Ethypharm announces today that it has entered into a definitive agreement to acquire Altan Pharma, a specialty pharmaceutical company that develops, manufactures and markets injectable medicines for hospital use.

June 18, 2021

·

3 min read

Business

Jean MONIN Appointed Chief Commercial Operations Officer (CCOO) of the Ethypharm Group

The Ethypharm Group is delighted to announce the appointment of Jean MONIN as Group CCOO.

January 29, 2019

·

2 min read

Medexus Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with EthypharmDrug shortage in the United States driving need for Triamcinolone Hexacetonide

Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce it has entered into an exclusive license agreement with Ethypharm (“Ethypharm”) to register and commercialize Triamcinolone Hexacetonide Injectable Suspension 20 mg/mL (“TH”) in the United States.

December 18, 2020

·

6 min read

Deals

Ethypharm Release: Company Acquires Martindale Pharma In The UK

January 19, 2017

·

2 min read

Deals

Ethypharm Acquires DB ASHBOURNE LTD In The United Kingdom

October 1, 2015

·

2 min read

Deals

Luye Pharma Group Ltd. Bids To Acquire France’s Ethypharm In Deal Worth Up To $900 Million

April 1, 2016

·

1 min read

Business

Meda AB Expands Axorid Collaboration With Ethypharm

December 30, 2009

·

1 min read

Policy

Oscient Pharmaceuticals Corporation and Ethypharm File Lawsuit Against Lupin for Infringement of ANTARA(R) Patent

January 15, 2009

·

1 min read